Bio Rad Laboratories Inc/ US0905722072 /
26/09/2024 22:10:00 | Chg. +16.55 | Volume | Bid14:31:50 | Ask14:31:50 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
332.10USD | +5.24% | 209,760 Turnover: 34.5 mill. |
314.01Bid Size: 100 | 531.36Ask Size: 200 | 7.57 bill.USD | - | - |
GlobeNewswire
12/08
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection i...
GlobeNewswire
24/06
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Lea...
GlobeNewswire
03/06
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
GlobeNewswire
29/03/2022
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital...
GlobeNewswire
22/03/2022
Iridia Announces Appointment of Thomas H. Cauley, Ph.D. as Vice President, Engineering
GlobeNewswire
03/08/2021
Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors
GlobeNewswire
01/06/2021
RNA Disease Diagnostics Further Strengthens Executive Leadership with Appointment of John W. Erickso...
GlobeNewswire
24/08/2020
Landec Nominates Three New Members to its Board of Directors, Providing Deep Expertise to Both Busin...
GlobeNewswire
04/05/2020
Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...
Newsfile Corp
16/04/2020
LexaGene CEO Discusses COVID-19 Testing, Commercialization Strategy -- SECFilings.com
GlobeNewswire
20/03/2020
Natus Medical Announces the Appointment of Ilan Daskal to the Board of Directors
Newsfile Corp
09/03/2020
Coronavirus Highlights Need for Rapid Testing of Pathogens -- SECFilings.com